Healthcare | August 03, 2021
Nureca Ltd PAT at Rs 36.19 crore in Q1FY22
Nureca Ltd has reported financial results for the period ended June 30, 2021.
Nureca Ltd has reported financial results for the period ended June 30, 2021.
Turnover of API division of ISLL stood at Rs 856.58 crore
The company reported total income of Rs.1215.73 crores during the period ended June 30, 2021.
SteriScience will infuse an additional amount of Rs. 74.5 crore, making a total investment commitment of Rs. 114.5 crore in BSL
Oxygen Park is a concept where a two-layer layout is being used to plant oxygen releasing trees which releases oxygen for 24 hours
The TWYMEEG approval is supported by numerous preclinical and clinical studies, including the Phase 3 TIMES (Trials of IMeglimin for Efficacy and Safety) program managed jointly by both the companies
The company has predominantly built a portfolio into veterinary products
This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent
With the acquisition of these further shares, TWPL has now become company's subsidiary.
The company has launched Perampil, at 2 mg (Rs. 49/strip of 7 tablets), 4 mg (Rs. 180/strip of 15 tablets) and 6 mg (Rs. 300/strip of 15 tablets) to improve patient access
Subscribe To Our Newsletter & Stay Updated
